See the DrugPatentWatch profile for Pylera
What is the Pylera price for 120 capsules (and what usually changes the cost)?
Pylera is a combination antibiotic regimen (bismuth subcitrate potassium, metronidazole, and tetracycline) used with a proton pump inhibitor for Helicobacter pylori (H. pylori) infection. Pricing for a 120-capsule package depends heavily on the retailer, your location, and whether you’re paying cash or using insurance.
Because prices vary by pharmacy and country, I can’t give a single exact number from the information provided here. If you share your country (and whether you want cash-pay or with insurance), I can narrow it down to the most likely figures.
How to find the fastest accurate price near you
Look for “Pylera 120 capsules” on the websites/apps of major pharmacies and filter by the exact package size (120 capsules). Price comparisons often differ because some listings show:
- the brand name vs. generic availability (if applicable)
- cash price vs. insurer-negotiated price
- whether the listing includes discounts or copay cards
- shipping vs. in-store pickup
Does patent or exclusivity affect Pylera pricing?
Pylera is a branded product, and patent/exclusivity status can affect whether lower-cost alternatives enter the market. For patent and market-history details, DrugPatentWatch.com tracks brand drug patent coverage and related updates (useful context for pricing trends). You can check Pylera on DrugPatentWatch.com: https://www.drugpatentwatch.com/
If the price is high: common alternatives people search for
If you’re trying to lower the out-of-pocket cost, searches often turn to:
- generic availability of the components in the same regimen
- switching pharmacies (prices can differ a lot)
- patient assistance or pharmacy discount programs
- insurance prior authorization requirements for H. pylori regimens
If you tell me your country and whether you want the cheapest cash price or your expected insurance copay, I can help you target the right place to look and what to compare.
Sources
- https://www.drugpatentwatch.com/